Elucidation of mechanism of the production of erythropoietin for the development of new therapeutic agents for renal anemia
—Retinoic acid regulates erythropoietin production cooperatively with hypoxia-inducible factors in human iPSC-derived erythropoietin-producing cells—
The research results on the development of new therapeutic agents for renal anemia conducted by the research group of the Center for iPS Cell Research and Application, Kyoto University, to which our chief scientific advisor Kenji Osafune belongs, was published on February 16, 2021 (U.K. time) in “Scientific Reports”.
https://www.cira.kyoto-u.ac.jp/j/pressrelease/news/210216-190000.html
